Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia

被引:28
作者
Dinner, Shira [1 ]
Lee, Daniel [2 ]
Liedtke, Michaela [1 ]
机构
[1] Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
关键词
Acute lymphoblastic leukemia; salvage chemotherapy; immunotherapy; DOSE CYTOSINE-ARABINOSIDE; INOTUZUMAB OZOGAMICIN CMC-544; ACUTE LYMPHOCYTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; PHASE-I; INDUCTION THERAPY; ADULT PATIENTS; ONCOLOGY-GROUP; T-CELLS; PROGNOSTIC-SIGNIFICANCE;
D O I
10.3109/10428194.2013.856428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite high rates of complete remission in newly diagnosed adult acute lymphoblastic leukemia (ALL), rates of long-term leukemia-free survival are disappointingly low. Treatment of relapsed disease with chemotherapy, even in patients able to pursue consolidation with allogeneic stem cell transplant, has demonstrated limited success. There are no established standards of care in this setting and few standard treatment options. Novel agents targeting antigens on the lymphoblast cell surface offer unique side effect and anti-leukemic profiles which suggest that their use alone or in combination with chemotherapy may achieve improved outcomes for relapsed or refractory ALL.
引用
收藏
页码:1715 / 1724
页数:10
相关论文
共 71 条
[1]  
Advani A, 2012, BLOOD S1, V120
[2]   Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia [J].
Advani, Anjali S. ;
Gundacker, Holly M. ;
Sala-Torra, Olga ;
Radich, Jerald P. ;
Lai, Raymond ;
Slovak, Marilyn L. ;
Lancet, Jeffrey E. ;
Coutre, Steve E. ;
Stuart, Robert K. ;
Mims, Martha P. ;
Stiff, Patrick J. ;
Appelbaum, Frederick R. .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (05) :430-434
[3]   A Phase II Study of Campath-1H in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia: A Children's Oncology Group Report [J].
Angiolillo, Anne L. ;
Yu, Alice L. ;
Reaman, Gregory ;
Ingle, Ashish M. ;
Secola, Rita ;
Adamson, Peter C. .
PEDIATRIC BLOOD & CANCER, 2009, 53 (06) :978-983
[4]  
ARLIN ZA, 1991, LEUKEMIA, V5, P712
[5]   Tumor regression in cancer patients by very low doses of a T cell-engaging antibody [J].
Bargou, Ralf ;
Leo, Eugen ;
Zugmaier, Gerhard ;
Klinger, Matthias ;
Goebeler, Mariele ;
Knop, Stefan ;
Noppeney, Richard ;
Viardot, Andreas ;
Hess, Georg ;
Schuler, Martin ;
Einsele, Hermann ;
Brandl, Christian ;
Wolf, Andreas ;
Kirchinger, Petra ;
Klappers, Petra ;
Schmidt, Margit ;
Riethmueller, Gert ;
Reinhardt, Carsten ;
Baeuerle, Patrick A. ;
Kufer, Peter .
SCIENCE, 2008, 321 (5891) :974-977
[6]  
Berg SL, 2003, BLOOD S1, V102
[7]   CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].
Brentjens, Renier J. ;
Davila, Marco L. ;
Riviere, Isabelle ;
Park, Jae ;
Wang, Xiuyan ;
Cowell, Lindsay G. ;
Bartido, Shirley ;
Stefanski, Jolanta ;
Taylor, Clare ;
Olszewska, Malgorzata ;
Borquez-Ojeda, Oriana ;
Qu, Jinrong ;
Wasielewska, Teresa ;
He, Qing ;
Bernal, Yvette ;
Rijo, Ivelise V. ;
Hedvat, Cyrus ;
Kobos, Rachel ;
Curran, Kevin ;
Steinherz, Peter ;
Jurcic, Joseph ;
Rosenblat, Todd ;
Maslak, Peter ;
Frattini, Mark ;
Sadelain, Michel .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)
[8]   Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia [J].
Brüggemann, M ;
Raff, T ;
Flohr, T ;
Gökbuget, N ;
Nakao, M ;
Droese, J ;
Lüschen, S ;
Pott, C ;
Ritgen, M ;
Scheuring, U ;
Horst, HA ;
Thiel, E ;
Hoelzer, D ;
Bartram, CR ;
Kneba, M .
BLOOD, 2006, 107 (03) :1116-1123
[9]   Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study [J].
Chevallier, Patrice ;
Robillard, Nelly ;
Charbonnier, Aude ;
Raffoux, Emmanuel ;
Maury, Sebastien ;
Carras, Sylvain ;
Chabrot, Cecile ;
Fohrer, Cecile ;
Bernard, Marc ;
Blade, Jean-Sebastien ;
Etienne, Anne ;
Talmant, Pascaline ;
Delaunay, Jacques ;
Guillaume, Thierry ;
Mohty, Mohamad ;
Bene, Marie-Christine ;
Ifrah, Norbert ;
Dombret, Herve .
BLOOD, 2012, 119 (11) :2474-2477
[10]  
Cooper T, 2003, P AM ASSOC CANC RES, V44, P142